Medical News

RSS

Nearly one third of patients with advanced melanoma saw tumors disappear completely after receiving TIL therapy plus pembrolizumab immunotherapy

Results from a clinical trial have revealed nearly one third (29.2 percent) of patients with advanced melanoma saw their tumors disappear completely on scans after receiving lifileucel TIL therapy alongside an immune checkpoint inhibitor, pembrolizumab, as a first-line treatment.

24 Oct 2026

Newly discovered protein controls the space between mitochondrial membranes

Mitochondria are the tiny powerpacks that supply most of the energy our cells need. Their ability to generate this energy relies on a distinctive architecture: two membranes, one tucked inside the other, separated by a narrow gap called the intermembrane space (IMS).

23 Oct 2026

LGBTQ+ college students facing discrimination report higher mental health risks

LGBTQ+ college students who experience discrimination are significantly more likely to experience depression, anxiety, suicidal thoughts, and avoid needed health care, according to a new national study by Columbia University Mailman School of Public Health, Boston University School of Public Health and Harvard Pilgrim Health Care Institute.

23 Oct 2026

Movement helps people learn complex patterns more effectively, study finds

Punching a virtual response box or swinging a virtual lightsaber can dramatically improve learning on certain tasks, according to new research from Florida Atlantic University's College of Engineering and Computer Science, which challenges long-standing assumptions about how people learn.

23 Oct 2026

Six-gene score could improve survival predictions for acute myeloid leukemia

The activity of six different genes can help determine patient survival of acute myeloid leukemia (AML), according to a study published today in Science Advances.

23 Oct 2026

Study reveals how cancer cells survive chemotherapy in a zombie-like state

Scientists at Trinity College Dublin have made an important breakthrough in understanding how cancer cells can evade the cell-killing effects of chemotherapy and enter a "zombie-like state", called premature senescence, that can attract the wound healing properties of the immune system.

23 Oct 2026

Taurine helps regulate inflammation linked to aging, Yale study finds

Sustained low-level inflammation is a hallmark of the aging process. The accumulating damage persistently activates the innate immune system-the body's first line of defense-leading to what is known as inflammaging, functional decline and chronic diseases of old age.

23 Oct 2026

Nephrologist shortages linked to higher kidney disease mortality along US-Mexico borde

New research indicates that US-Mexico border counties experience disproportionately elevated rates of death from chronic kidney disease (CKD), alongside reduced availability of nephrologists. The findings will be presented at ASN Kidney Week 2026 October 22–25.

23 Oct 2026

New guidance expands reproductive care for people with cystic fibrosis

For much of the history of cystic fibrosis (CF) care, reproductive health was not a major part of the conversation. Fertility challenges were the norm for men and women with this genetic disorder, and many grew up assuming biological parenthood was not possible.

23 Oct 2026

Novel immunosuppressant improves kidney function and quality of life after transplantation

The Phase 2 BESTOW clinical trial showed that tegoprubart (a novel anti-CD40L antibody therapy) was better at preserving kidney function than tacrolimus (the current standard of care) in immunosuppressive regimens in adults receiving their first kidney transplant.

23 Oct 2026

Common kidney tests underestimate chronic kidney disease in cancer patients

New research indicates that commonly used measures of kidney function largely underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026 October 22–25.

23 Oct 2026

KRAS-targeting vaccine prompts immune responses in pancreatic cancer patients

An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers.

23 Oct 2026

Shared meiosis proteins show surprising functional differences across animals

Every egg cell and sperm cell depends on meiosis, a tightly choreographed process in which chromosomes find their partners, exchange genetic material, and then divide.

23 Oct 2026

Digital tools and phone coaching boost cancer genetic testing uptake

About 10% of cancers are linked to an inherited genetic variant, but as few as 1 in 15 cancer patients eligible for genetic testing complete it.

23 Oct 2026

$New ultrasound platform detects early-stage stress fractures without radiation$

New ultrasound platform detects early-stage stress fractures without radiation

Tibial stress fractures are among the most common overuse injuries affecting military personnel, but they can be difficult to identify in their earliest stages.

23 Oct 2026

Targeted drug extends survival across diverse pancreatic cancer patient groups

A new analysis of a phase 3 clinical trial found that the targeted drug daraxonrasib improved survival compared with standard chemotherapy across multiple groups of patients with advanced pancreatic cancer, including those with different RAS mutations and those without an identified RAS mutation.

23 Oct 2026

EEG monitoring offers new way to detect cybersickness

For years, developers of virtual reality (VR) and augmented reality (AR) technologies have worked to address an unwanted side effect many users experience: cybersickness, a type of motion sickness triggered by moving digital content.

23 Oct 2026

PARP1 remodels nucleosomes to help cells repair damaged DNA

When DNA is damaged, cellular processes respond and repair the DNA. Inhibiting DNA damage repair can be therapeutically beneficial in cancers with genetic vulnerabilities related to DNA damage response.

23 Oct 2026

ECDC urges preparedness as Ebola cases emerge in Africa

With cases of Ebola disease caused by Bundibugyo virus recently detected in Kenya and Nigeria, in a new report published today the European Center for Disease Prevention and Control (ECDC) reiterates the low risk for Europe while highlighting the need for preparedness.

23 Oct 2026

Researchers call for microbiome moonshot to tackle chronic diseases

Rutgers researchers are part of an international call for a microbiome moonshot, a massive, coordinated effort to pinpoint how certain microorganisms inside us drive chronic disease and how others can be harnessed for repair.

23 Oct 2026